Proportion of hospital deaths associated with adverse events

Journal of Clinical Epidemiology
M García-MartínR Gálvez-Vargas

Abstract

To determine the fraction of hospital deaths potentially associated with the occurrence of adverse events (AE). A paired (1:1) case-control study. An 800-bed, teaching tertiary care hospital. All patients older than 14 years admitted to the hospital between January 1, 1990, and January 1, 1991, were eligible. All 524 consecutive deaths (death rate of 3.74%) that occurred in the hospital comprised the case group. For each case, a control patient was matched for both primary diagnosis on admission and admission date. The proportion of hospital deaths associated with adverse events (defined as problems of any nature and seriousness faced by the patient during hospitalization, and potentially traceable to clinical or administrative management) was estimated from attributable risks adjusted for age, sex, service, severity of illness, length of stay, and quality of the medical record. For stays longer than 48 hours, the adjusted attributable risk for all adverse events was estimated to be 0.51 (0.40-0.61). When the data were stratified according to the category of adverse event, the attributable risks remained significant except for administrative problems. The greatest proportion of deaths associated with adverse events was observed...Continue Reading

References

Jul 18, 1991·The New England Journal of Medicine·W Drucker
Aug 17, 1989·The New England Journal of Medicine·H H HiattK E Thorpe
Jun 1, 1988·American Journal of Infection Control·J S GarnerJ M Hughes
Jun 18, 1988·Lancet·P F Infante, M V DiStasio
Apr 1, 1988·Statistics in Medicine·S J Kuritz, J R Landis
Oct 1, 1988·Annals of Internal Medicine·R W Dubois, R H Brook
Dec 24, 1987·The New England Journal of Medicine·R W DuboisR H Brook
Oct 1, 1985·Critical Care Medicine·W A KnausJ E Zimmerman
Oct 1, 1983·The American Journal of Medicine·P A Gross, C Van Antwerpen
Mar 12, 1981·The New England Journal of Medicine·K SteelJ Anderson
Dec 1, 1994·The Journal of Hospital Infection·R H Dinkel, U Lebok
Dec 1, 1994·Annals of Internal Medicine·L A PetersenT H Lee
Jan 1, 1964·Annals of Internal Medicine·E M SCHIMMEL

❮ Previous
Next ❯

Citations

Aug 31, 2002·International Journal for Quality in Health Care : Journal of the International Society for Quality in Health Care·A K KableA D Spigelman
Oct 21, 2009·International Journal for Quality in Health Care : Journal of the International Society for Quality in Health Care·Jesus M Aranaz-AndrésUNKNOWN ENEAS work group
Jun 24, 2003·Archives of Disease in Childhood·T DukeUNKNOWN Paediatric Quality Care Group
Mar 17, 2000·BMJ : British Medical Journal·S N WeingartB Harrison
Sep 21, 2011·BMC Health Services Research·Mônica MartinsAna Luiza B Pavão
Jun 14, 2014·Journal of Neurosurgery·Adetunji A Oremakinde, Mark Bernstein
Aug 10, 2004·Journal of the American Medical Informatics Association : JAMIA·Aziz A BoxwalaLuke Sato
Jan 24, 2012·Revista de calidad asistencial : organo de la Sociedad Española de Calidad Asistencial·C González SteinbauerV Zanón Viguer
Dec 7, 2010·Neurología : publicación oficial de la Sociedad Española de Neurología·R Alberca
Oct 28, 2003·Research in Nursing & Health·Victoria A Kellogg, Donna Sullivan Havens
Feb 15, 2002·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·M García-MartínR Gálvez-Vargas
Aug 26, 2004·Revista brasileira de psiquiatria : orgão oficial da Associação Brasileira de Psiquiatria, Asociación Psiquiátrica de la América Latina·Elisaldo Luiz de Araújo Carlini, Solange Aparecida Nappo
Dec 25, 2004·The Journal of Hospital Infection·B KaoutarUNKNOWN French Hosptial Mortality study group
Jan 17, 2013·JRSM Short Reports·Olanrewaju O SorinolaRuth Brown
Sep 23, 2006·The Neurologist·Olav Jaren, Linda Selwa
Jul 12, 2001·Statistical Methods in Medical Research·G E Eide, I Heuch
Jan 9, 2001·The Joint Commission Journal on Quality Improvement·S E FeldmanD W Roblin
Sep 2, 2021·Journal of Patient Safety·Khara M SauroHenry T Stelfox

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

The Journal of Hospital Infection
J Fabry, J Carlet
International Journal for Quality in Health Care : Journal of the International Society for Quality in Health Care
A M SalinasM Zambrana
© 2021 Meta ULC. All rights reserved